Health Canada
- Status: approved
🇨🇦 Glucagon-like peptide-1 receptor agonist：Semaglutide in Canada
Glucagon-like peptide-1 receptor agonist：Semaglutide (Glucagon-like peptide-1 receptor agonist：Semaglutide) regulatory status in Canada.
Marketing authorisation
Glucagon-like peptide-1 receptor agonist：Semaglutide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Glucagon-like peptide-1 receptor agonist：Semaglutide approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Glucagon-like peptide-1 receptor agonist：Semaglutide in Canada?
The First Affiliated Hospital with Nanjing Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.